M 422 (Hydrochlorothiazide and Olmesartan Medoxomil 12.5 mg / 40 mg)
Pill with imprint M 422 is Pink, Capsule-shape and has been identified as Hydrochlorothiazide and Olmesartan Medoxomil 12.5 mg / 40 mg. It is supplied by Mylan Pharmaceuticals Inc..
Hydrochlorothiazide/olmesartan is used in the treatment of high blood pressure and belongs to the drug class angiotensin II inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/olmesartan 12.5 mg / 40 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M 422
Hydrochlorothiazide and Olmesartan Medoxomil
- Imprint:
- M 422
- Strength:
- 12.5 mg / 40 mg
- Color:
- Pink
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Angiotensin II inhibitors with thiazides
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-1422
More about hydrochlorothiazide/olmesartan
- Hydrochlorothiazide/olmesartan Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 29 Reviews
- Drug class: angiotensin II inhibitors with thiazides
Consumer resources
- Hydrochlorothiazide and olmesartan
- Olmesartan and Hydrochlorothiazide
- Olmesartan and hydrochlorothiazide (Advanced Reading)
Other brands: Benicar HCT
Professional resources
- Olmesartan Medoxomil and Hydrochlorothiazide (FDA)
- Olmesartan and Hydrochlorothiazide (Wolters Kluwer)
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
